The overall goal of Core C (Animal Model Core) is to support the development and use of the animal models employed within this Program Project Grant (PPG). The guiding principals for the animal model core are efficient planning and utilization of animals, standardization of processing and diagnoses, reliability of service and consistent evaluation of animal models and being a cost center for all animal costs. The fundamental expertise provided within the core is laboratory animal medicine and clinical and anatomic pathology. The Core is housed and coordinated in the Department of Veterinary Biosciences. Dr. Stefan Niewiesk, proposed Core Director has been co-director of the Animal Core since 2004 and is an active collaborator with all of the principal investigators for the PPG. He is certified in Veterinary Microbiology and as a Laboratory Animal Medicine Veterinarian (European). Because of Dr. Niewiesk's unique training, he also provides expertise in the generation of monoclonal and polyclonal antibodies for specific projects for the PPG. Dr. Thomas Rosol (Project 4, Co-Pi), who is certified by the American College of Veterinary Pathologist will serve as co-director for the Core. These investigators are joined by experienced technical staff to form a highly experienced professional team to guide the Core and meet the goals of the PPG investigators. A common thread among all research groups is the shared use of unique infectious molecular clones of HTLV-1 and HTLV-2, developed or characterized in our laboratories and links to established animal models to test molecular determinants of disease. Since 2003, the investigators have further evolved multiple new interdependent methods, techniques, and synergistic exchanges that serve to integrate their science to approach basic biological paradigms as desired outcomes from the project laboratories. The highly interactive Animal Core directed by Dr. Niewiesk will provide a central purchasing and procurement method to facilitate animal studies and to reduce redundancy and promote collaborations among the projects. A unique role of the Animal Core will be to provide faculty with expertise in mouse pathology, and provide state-of-the-art methods to determine and quantify bone lesions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA100730-09
Application #
8300000
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-05-31
Budget End
2012-05-30
Support Year
9
Fiscal Year
2011
Total Cost
$297,277
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Huey, Devra D; Niewiesk, Stefan (2018) Production of Humanized Mice through Stem Cell Transfer. Curr Protoc Mouse Biol 8:17-27
Romeo, Megan; Hutchison, Tetiana; Malu, Aditi et al. (2018) The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis. Virology 518:103-115
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Huey, Devra D; Bolon, Brad; La Perle, Krista M D et al. (2018) Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. Comp Med 68:4-14
Pérès, Eléonore; Blin, Juliana; Ricci, Emiliano P et al. (2018) PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice. PLoS Pathog 14:e1006933
Panfil, Amanda R; Al-Saleem, Jacob; Howard, Cory M et al. (2018) Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5. Front Microbiol 9:80
Ross, Michael H; Esser, Alison K; Fox, Gregory C et al. (2017) Bone-Induced Expression of Integrin ?3 Enables Targeted Nanotherapy of Breast Cancer Metastases. Cancer Res 77:6299-6312
Esser, Alison K; Rauch, Daniel A; Xiang, Jingyu et al. (2017) HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget 8:69250-69263
Fontana, Francesca; Ge, Xia; Su, Xinming et al. (2017) Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma. Clin Cancer Res 23:416-429

Showing the most recent 10 out of 162 publications